| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXSB2300066 | 注射用德曲妥珠单抗（DS-8201a） | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2023-05-31 | view |